# Influence of HLA-DQA1*05 Genotype in Adults With Anti-TNF Treatment With Proactive Therapeutic Drug Monitoring.

> **NCT05986903** · — · UNKNOWN · sponsor: **Hospital del Rio Hortega** · enrollment: 280 (estimated)

## Conditions studied

- Drug Monitoring
- Inflammatory Bowel Diseases

## Interventions

- **DRUG:** Tumor necrosis factor (TNF)-alpha inhibitors

## Key facts

- **NCT ID:** NCT05986903
- **Lead sponsor:** Hospital del Rio Hortega
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-11
- **Primary completion:** 2024-02-01
- **Final completion:** 2025-01-01
- **Target enrollment:** 280 (ESTIMATED)
- **Last updated:** 2023-08-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05986903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05986903, "Influence of HLA-DQA1*05 Genotype in Adults With Anti-TNF Treatment With Proactive Therapeutic Drug Monitoring.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05986903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*